Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Accelerate Diagnostics Inc (AXDX) Insider Trading Activity
Healthcare • Medical Devices • 134 employees
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Total Value
$9,345.25
Total Shares
515
Average Trade Value
$2,336.31
Most Active Insider
Schuler Jack W
Total Activity: $314,000
Largest Single Transaction
$314,000
by Schuler Jack W on Dec 3, 2024
30-Day Activity
2 Transactions
Volume: 515 shares
Value: $9,345
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Chief Executive Officer
Director, Officer
|
Feb 3, 2025 | 485 | $655 | 163,434 (-0.3%) | Sale | |
Chief Executive Officer
Director, Officer
|
Feb 1, 2025 | 1,000 | $10,000 | 163,919 (+0.6%) | Exercise/Conversion | |
Director, 10% Owner
|
Dec 3, 2024 | 200,000 | $314,000 | 8,310,388 (-2.4%) | Sale | |
Director
|
Dec 3, 2024 | 200,000 | $314,000 | 653,224 (+30.6%) | Purchase |